Rare diseases
Investigational molecules
Locations
Back to Germany22 clinical trials in Böblingen, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyA study to evaluate the safety and effectiveness of dextromethorphan, deramciclane fumarate, and deramciclane in treating agitation in people with Alzheimer's disease
GermanyStudy on Long-Term Safety of KarXT (Trospium Chloride, Xanomeline Tartrate) for Patients with Alzheimer's-Related Psychosis
GermanyStudy Comparing Sacituzumab Govitecan Alone and with Pembrolizumab for Patients with Low-Risk, Triple-Negative Early Breast Cancer
GermanyStudy on the Effects of Amylase, Protease, and Rizolipase for Patients After Gastrectomy
GermanyOral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type
GermanyStudy on LY3848575 for Reducing Pain in Patients with Distal Sensory Polyneuropathy
GermanyStudy on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments
GermanyStudy on the Effectiveness and Safety of AVP-786 (Quinidine Sulfate and Deudextromethorphan Hydrobromide) for Treating Agitation in Alzheimer's Dementia Patients
GermanyStudy on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials
GermanyStudy on Fenebrutinib and Teriflunomide for Adults with Relapsing Multiple Sclerosis
GermanyStudy of sacituzumab govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment
GermanyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on multiple sclerosis treatments, including studies comparing new therapies like fenebrutinib and frexalimab with established treatments. Several trials are investigating novel approaches for both relapsing and primary progressive forms of MS.
Additional studies explore innovative treatments for migraine prevention in patients who haven't responded to conventional therapies.
Comprehensive research into major depressive disorder and schizophrenia, evaluating new therapeutic approaches. Trials include testing novel compounds for depression with anhedonia and long-term safety studies for schizophrenia treatments.
Studies also examine new formulations for ADHD treatment in adults, comparing immediate and modified-release medications.
Innovative trials in breast cancer treatment, particularly focusing on HER2-negative and triple-negative variants. Studies evaluate both neoadjuvant and adjuvant therapeutic approaches.
Additional research examines treatment strategies for locally advanced rectal cancer, comparing pre- and post-surgical interventions.
Critical research into Alzheimer's disease and related conditions, with studies focusing on treating associated symptoms like psychosis and agitation in dementia patients.
These trials aim to improve quality of life for patients with neurodegenerative disorders through targeted symptom management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
